Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Scientific Activity In biochemical and cell models, 5-AMINO-1MQ inhibits NNMT, reducing methyl transfer from S-adenosylmethionine to nicotinamide and altering downstream methyl-donor and nicotinamide metabolite pools
Early animal studiesmostly in primatesshowed promising weight reduction, though translating those results to humans remains uncertain
Retatrutide is an investigational triple incretin receptor agonist under clinical development by Eli Lilly, whilst 5-Amino-1MQ is a research chemical targeting the NNMT enzyme
the second bottle leaves a small margin
The sleep and nutrition changes in particular benefit from at least two weeks of consistency before starting therapy
